Arkolith/Insider Trading/LCTX/Form 4

Howe Jill Ann

Chief Financial OfficerLineage Cell Therapeutics, Inc. (LCTX) · full profile →Form 4 · filed Aug 19, 2024
Net Buying
Open-Market Buys
$9K
Open-Market Sells
$0
Net Open-Market Flow
$9K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 16, 2024Buy(P)11K$0.89$9K11K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-098731) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML